David P Arnott - Publications

Affiliations: 
Genentech, Inc., San Francisco, CA, United States 

20 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Pham V, Pitti R, Tindell CA, Cheung TK, Masselot A, Stephan JP, Guler GD, Wilson C, Lill J, Arnott D, Classon M. Proteomic analyses identify a novel role for EZH2 in the initiation of cancer cell drug tolerance. Journal of Proteome Research. PMID 32159963 DOI: 10.1021/acs.jproteome.9b00773  0.332
2018 Raisner R, Kharbanda S, Jin L, Jeng E, Chan E, Merchant M, Haverty PM, Bainer R, Cheung T, Arnott D, Flynn EM, Romero FA, Magnuson S, Gascoigne KE. Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. Cell Reports. 24: 1722-1729. PMID 30110629 DOI: 10.1016/J.Celrep.2018.07.041  0.302
2016 Egan B, Yuan CC, Craske ML, Labhart P, Guler GD, Arnott D, Maile TM, Busby J, Henry C, Kelly TK, Tindell CA, Jhunjhunwala S, Zhao F, Hatton C, Bryant BM, et al. An Alternative Approach to ChIP-Seq Normalization Enables Detection of Genome-Wide Changes in Histone H3 Lysine 27 Trimethylation upon EZH2 Inhibition. Plos One. 11: e0166438. PMID 27875550 DOI: 10.1371/Journal.Pone.0166438  0.709
2016 Doll S, Urisman A, Oses-Prieto JA, Arnott D, Burlingame AL. Quantitative proteomics reveals fundamental regulatory differences in oncogenic HRAS and IDH1 driven astrocytoma. Molecular & Cellular Proteomics : McP. PMID 27834733 DOI: 10.1074/Mcp.M116.063883  0.319
2016 Vinogradova M, Gehling VS, Gustafson A, Arora S, Tindell CA, Wilson C, Williamson KE, Guler GD, Gangurde P, Manieri W, Busby J, Flynn EM, Lan F, Kim HJ, Odate S, ... ... Arnott D, et al. An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells. Nature Chemical Biology. PMID 27214401 DOI: 10.1038/Nchembio.2085  0.686
2015 Maile TM, Izrael-Tomasevic A, Cheung T, Guler GD, Tindell C, Masselot A, Liang J, Zhao F, Trojer P, Classon M, Arnott D. Mass spectrometric quantification of histone post-translational modifications by a hybrid chemical labeling method. Molecular & Cellular Proteomics : McP. 14: 1148-58. PMID 25680960 DOI: 10.1074/mcp.O114.046573  0.727
2014 Lin S, Wein S, Gonzales-Cope M, Otte GL, Yuan ZF, Afjehi-Sadat L, Maile T, Berger SL, Rush J, Lill JR, Arnott D, Garcia BA. Stable-isotope-labeled histone peptide library for histone post-translational modification and variant quantification by mass spectrometry. Molecular & Cellular Proteomics : McP. 13: 2450-66. PMID 25000943 DOI: 10.1074/mcp.O113.036459  0.696
2011 Phu L, Izrael-Tomasevic A, Matsumoto ML, Bustos D, Dynek JN, Fedorova AV, Bakalarski CE, Arnott D, Deshayes K, Dixit VM, Kelley RF, Vucic D, Kirkpatrick DS. Improved quantitative mass spectrometry methods for characterizing complex ubiquitin signals. Molecular & Cellular Proteomics : McP. 10: M110.003756. PMID 21048196 DOI: 10.1074/Mcp.M110.003756  0.36
2007 Mollah S, Wertz IE, Phung Q, Arnott D, Dixit VM, Lill JR. Targeted mass spectrometric strategy for global mapping of ubiquitination on proteins Rapid Communications in Mass Spectrometry. 21: 3357-3364. PMID 17883243 DOI: 10.1002/Rcm.3227  0.615
2007 Arnott D, Gawinowicz MA, Kowalak JA, Lane WS, Speicher KD, Turck CW, West KA, Neubert TA. ABRF-PRG04: differentiation of protein isoforms. Journal of Biomolecular Techniques : Jbt. 18: 124-34. PMID 17496225  0.327
2005 Stults JT, Arnott D. Proteomics. Methods in Enzymology. 402: 245-89. PMID 16401512 DOI: 10.1016/S0076-6879(05)02008-2  0.632
2005 Loyet KM, Stults JT, Arnott D. Mass spectrometric contributions to the practice of phosphorylation site mapping through 2003: a literature review. Molecular & Cellular Proteomics : McP. 4: 235-45. PMID 15640519 DOI: 10.1074/Mcp.R400011-Mcp200  0.592
2003 Arnott D, Gawinowicz MA, Grant RA, Neubert TA, Packman LC, Speicher KD, Stone K, Turck CW. ABRF-PRG03: phosphorylation site determination. Journal of Biomolecular Techniques : Jbt. 14: 205-15. PMID 13678151  0.327
2002 Arnott D, Kishiyama A, Luis EA, Ludlum SG, Marsters JC, Stults JT. Selective detection of membrane proteins without antibodies: a mass spectrometric version of the Western blot. Molecular & Cellular Proteomics : McP. 1: 148-56. PMID 12096133 DOI: 10.1074/Mcp.M100027-Mcp200  0.66
2000 Appella E, Arnott D, Sakaguchi K, Wirth PJ. Proteome mapping by two-dimensional polyacrylamide gel electrophoresis in combination with mass spectrometric protein sequence analysis. Exs. 88: 1-27. PMID 10803368  0.398
1999 Champion KM, Arnott D, Henzel WJ, Hermes S, Weikert S, Stults J, Vanderlaan M, Krummen L. A two-dimensional protein map of Chinese hamster ovary cells. Electrophoresis. 20: 994-1000. PMID 10344277 DOI: 10.1002/(Sici)1522-2683(19990101)20:4/5<994::Aid-Elps994>3.0.Co;2-N  0.604
1998 Arnott D, Henzel WJ, Stults JT. Rapid identification of comigrating gel-isolated proteins by ion trap- mass spectrometry Electrophoresis. 19: 968-980. PMID 9638943 DOI: 10.1002/Elps.1150190612  0.657
1998 Arnott D, O'Connell KL, King KL, Stults JT. An integrated approach to proteome analysis: identification of proteins associated with cardiac hypertrophy. Analytical Biochemistry. 258: 1-18. PMID 9527842 DOI: 10.1006/Abio.1998.2566  0.655
1996 Arnott DP, Henzel WJ, Stults JT. Identification of Proteins from Two-Dimensional Electrophoresis Gels by Peptide Mass Fingerprinting Acs Symposium Series. 619: 226-243.  0.659
1993 Arnott D, Shabanowitz J, Hunt DF. Mass spectrometry of proteins and peptides: sensitive and accurate mass measurement and sequence analysis Clinical Chemistry. 39: 2005-2010. DOI: 10.1093/Clinchem/39.9.2005  0.557
Show low-probability matches.